SCHEMBL5698454

SCHEMBL5698454

CCc1[nH]nc2c3ccccc3c3cnccc3c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 3/20 0.45
BRAF P15056 1/20 0.41
EIF2AK3 Q9NZJ5 1/20 0.41
PARP1 P09874 3/20 0.37
KDM4E B2RXH2 3/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HTR6 P50406 2/20 0.36
TOP2A P11388 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
GMNN O75496 1/20 0.36
LMNA P02545 1/20 0.36
NR3C1 P04150 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
LCK P06239 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5698452 0.75 KDM4E (0.44) KDM4EALDH1A1HPGDSMN1; SMN2HTR6
Hydrochloric Acid SCHEMBL5698504 0.73 PARP1 (0.36) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5698624 0.72 KDM4E (0.45) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL22048844 0.70 PARP1 (0.52) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL15374747 0.70 PARP1 (0.55) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL15374721 0.70 PARP1 (0.55) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL17298998 0.70 PARP1 (0.55) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL743939 0.70 PARP1 (0.55) PARP1KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL5698501 0.69 MKNK1 (0.39) PARP1PIM1PIM2
Hydrochloric Acid SCHEMBL5698636 0.68 KDM4E (0.43) PARP1KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed